Evidence map›Paper›PMID 38465344›Full record

ArticleOpen life sciences2024

Preparation of Cu

Xu Haitao, Li Siyuan, Guo Sutong, Guo Yu, Xu Peirong, Wang Ling, Ding Yujian, Feng Dehong

Abstract read
In one paragraph

Article in Open life sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xu HaitaoWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.
Li SiyuanSchool of Chemical and Material Engineering, Jiangnan University, Wuxi 214000, Jiangsu, China.
Guo SutongWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.
Guo YuWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.
Xu PeirongWuxi No. 5 People's Hospital, Wuxi 214000, Jiangsu, China.
Wang LingWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.
Ding YujianWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.
Feng DehongWuxi People's Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of stress shielding effects, traditional titanium (Ti) alloy scaffolds have a high elastic modulus, which might promote looseness and bone disintegration surrounding the implant, increasing the likelihood of a second surgery. In contrast, 3D-printed porous Ti alloy scaffolds can reduce the scaffold weight while enhancing biocompatibility. Further, these scaffolds' porous nature allows bone tissue ingrowth as well as strong pore connectivity, which can improve nutrient absorption. Nevertheless, bare Ti alloy implants may fail because of inadequate bone integration; hence, adding a coating on the implant surface is an effective technique for improving implant stability. In this study, a composite coating comprising hydroxyapatite (HAP), chitosan (CS), tannic acid (TA) and copper ions (Cu

Indexed as

3D printed porous titanium scaffoldsartificial bone graftschitosancomposite coatinghydroxyapatitenanoparticlesosteogenesis

Identifiers

PMID38465344
PMCPMC10921476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.